Cardiac regenerative strategies for interventionalist
15 Sep 2017 - From EUROPCR 2017
Can we create new myocardia and develop a “cure” for heart failure? Faced with an array of medical and device treatment, G.G Toth, D. Burkhoff and W. Wojakowski underline what is missing in current strategies apart from heart transplants – Do they actually have an effect on the missing or remodeled myocytes? How could interventionalists replace muscle cells that have been destroyed or altered? Current and past cell therapies are reviewed along with emerging data, types of cells tested as well as looking at delivery techniques or specific patient groups. Critical problems and limitations facing research are discussed to understand why advancing this therapy has been unsuccessful. Learn more…
2017 ESC Silver medalist and Andreas Grüntzig lecturer, MC Morice, speaks with 2017 ESC Gold medalist, William Wijns
40 years of angioplasty, 15 years of TAVI! Join MC Morice, this year’s Andreas Grüntzig lecturer and recipient of the 2017 ESC Silver Medal, in this conversation with W. Wijns, the ESC 2017 Gold medal awardee, as these two pioneers discuss their lifework. MC Morice looks at her ongoing commitment to research including her ground-breaking 1995 study on intracoronary stenting without Coumadin. W.Wijns, remembering the patient at the centre of our discipline, sees Stent for Life – with its positive effect on patient access to therapies and significant impact on morbidity and mortality – along with the educational activities of the PCR family, as part of his living legacy.
Renal denervation and uncontrolled hypertension – evolving data
06 Sep 2017
Can renal denervation have a positive effect on controlling blood pressure? F. Mahfoud reports from the ESC Congress 2017 in Barcelona as he introduces a late breaking trial which answers in the affirmative. Three-month results of the international SPYRAL HTN-OFF MED study demonstrated a “significant reduction in ambulatory and office blood pressure” in the denervation arm. Learning from earlier trials, discover how this new study could provide sound biological proof of principal, underlining the evolution in our understanding of anatomy and particularly in our approach to the technique itself. What does the future hold? What type of patient responds best? Find out more here…
How intravascular imaging can optimise PCI results
21 Aug 2017 - From EUROPCR 2017
Complex PCI, STEMI...does using IVUS really reduce major adverse cardiovascular events? Join C. Cook, Z. Ali and G. Guagliumi as they review the proper way to use this “irrefutable” imaging tool. Does IVUS have a role throughout a procedure? How should you prepare and map your strategy in advance? Leanr why they characterise this as “the essence of decision–making”? What does the future hold in store for these technologies? How can we move to more “objective” measurements? What is the importance of the upcoming trial comparing high-risk patients and high-risk lesion randomised to angiography against OCT? Learn more here…
Bifurcation stenting, when do I need two stents?
18 Aug 2017 - From EUROPCR 2017
Treating bifurcation lesions is a challenge, and the need to convert to a two-stent strategies can be daunting. Join experts G. G. Toth, T. Johnson and F. Mangiacapra as they discuss their own insights and suggestions, reminding us to never forget the provisional approach. What percentage of cases might necessitate converting to a two-stent technique? What elements in anatomy, lesion or the type of patient might require this change? Which two-stent strategy should you begin with – and practice? What imaging tools are useful and what possible role does functional assessment play? Watch video and find out…
PCRonline Journal Club
Looking for the online address where you can find reviews of the latest articles of interest chosen by your peers – articles that can have an impact on your practice today? PCRonline is dedicated to being your first-stop in knowing what’s going on in the world of interventional cardiology, in Europe and internationally! D. Milasinovic introduces us to the online community where you are not only invited to read an article, but comment as well! Join us!
Renal angioplasty and arteriovenous-fistula creation for hypertension
12 Jul 2017 - From EUROPCR 2017
Interventions for hypertension – where do we stand today? Can the reality of clinical practice differ from trials? S. Ewen, F. Sharif and M. D. Lobo review current evidence and experience with a look at the growing instance of renal artery stenosis or the possibility of a “mechanical” approach to treating resistant hypertension. Is there an association between renal artery stenosis and hypertension or chronic kidney disease? Can certain patients benefit from revascularisation? Why would AV fistula creation reducing systemic vascular resistance reduce blood pressure? What is the ROX CONTROL HTN study and how does it point the way to future avenues of treatment? Learn more.
How to treat patients with popliteal and common femoral artery lesions
12 Jul 2017 - From EUROPCR 2017
With peripheral interventions becoming more widespread, what are the challenges facing specialists in treating complex situations? C. Cook speaks with leading peripheral expert A. Micari about what he describes as “the worst part of the leg’s vascular tree”. Learn about the difficulties inherent in treating lesions in arteries subject to the forces of compression, flexion and torsion at the same time, or how restenosis has been an historic threat. What innovative devices and techniques are becoming available today that could offer a valid choice instead of surgery? What are our unmet needs and why is the field “ripe” for future developments? Watch now.
Management of patients with multilevel atherosclerosis
11 Jul 2017 - From EUROPCR 2017
While we are used to treating coronary artery disease, interventional cardiologists need to keep in mind that many of these patients have a silent form of vascular involvement because of atherosclerosis. S. Redwood, F. Ribichini and M. Roffi focus on this complex topic and the implications of taking charge of patients with diffuse disease. What current evidence exists in this often older and sicker population? On what level should management begin? Why is the best treatment one that is provided by a clinician working with a team of dedicated specialists in a “patient-centred” approach? Learn the details here…
Strategies and devices for the treatment of complex aortoiliac lesions
11 Jul 2017 - From EUROPCR 2017
From defining the disease, choosing the best patient and planning the intervention itself, all points are covered with peripheral experts E. Stabile and A. Sauguet in this detailed discussion. Learn why symptoms are not enough to classify your patient, why duplex echo followed by angio-CT are essential and what they tell us about anatomy, the complexity of the lesion or the amount of the calcium. Learn why planning strategy implies choosing the access route and why, in some cases, two different access sites might be required. Does device choice drive strategy as well? More here…